There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Six sigma, process analytical technology (PAT) and related initiatives are driving greater use of statistical analysis methods to increase process understanding and improve manufacturing capabilities.

Making data analysis lean

Also, Genmab will acquire PDL Pharma's Minnesota manufacturing facility, DSM Pharmaceuticals appointed Hans Engels president and business unit director, more...

Company and People Notes: Akorn Enters Supply Agreement, Vernalis Makes Changes to Senior Management Positions, More

Merck Capital Ventures, a subsidiary of Merck & Co., has invested $1.5 million to expand its service laboratory. The transaction with NanoImaging Services will add high-resolution, three-dimensional transmission electron microscope (TEM) capability, which allows biopharmaceutical researchers to see complex macromolecular structures they create with resolution as high as one nanometer.

Merck Invests $1.5 Million in TEM Imaging Service Laboratory

Angie Drakulich was editorial director of Pharmaceutical Technology.

The US Food and Drug Administration released a final guidance on protocol for testing sterile products.

Stability Testing Guidance Finalized

Also, Biocon will acquire 70% of AxiCorp, ARIAD Pharmaceuticals promoted Richard W. Pascoe to the new position of COO, more...

Company and People Notes: EUSA Pharma Makes Deal with GSK, BiPar Sciences Appoints Hoyoung Huh President and CEO, More

Chesapeake to relocate and expand, AVI BioPharma appoints CEO, More...

Company and People Notes: Chesapeake to Relocate and Expand, AVI BioPharma Appoints CEO, More

Amira and GSK Form Agreement, Xenome Appoints Ian Nisbet CEO, More...

Company and People Notes: Amira and GSK Form Agreement, Xenome Appoints Ian Nisbet CEO, More

PharmTech's polls feature user feedback on issues facing the pharmaceutical industry.

You're Telling Us...

Brief pharmaceutical news items for February 2008.

Pharma Capsules

USP 467 Residual Solvents will take effect on July 1, 2008. But does the industry understand these specifications-and is it prepared?

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes